Welcome to #1 DIGITAL HEALTH NEWS Portal

NHS IT Chiefs Set the Stage for a Year of Digital Transformation as Digital Health Rewired Returns to London

3 - 4 March 2019, London, United Kingdom.
NHS technology leaders are to kick off the second-ever Digital Health Rewired Conference and Exhibition on 3 - 4 March at the Olympia National, London. The much-expanded show, which will see a host of new tracks and events, is set to welcome thousands of key digital health leaders.

Read more ...

Human Body-on-Chip Platform Enables In Vitro Prediction of Drug Behaviors in Humans

Drug development is an extremely arduous and costly process, and failure rates in clinical trials that test new drugs for their safety and efficacy in humans remain very high. According to current estimates, only 13.8% of all tested drugs demonstrate ultimate clinical success and obtain approval by the Food and Drug Administration (FDA).

Read more ...

Brainlab Acquires VisionTree to Drive Patient-Reported Outcomes

Brainlab, the digital medical technology company, announced the recent acquisition of VisionTree Software, Inc., a San Diego based company that develops cloud-based, patient-centric data collection and health management solutions. The acquisition re-emphasizes the Brainlab commitment to

Read more ...

Integrate Micro Chips for Electronic Skin

Human skin is a fascinating and multifunctional organ with unique properties originating from its flexible and compliant nature. It allows for interfacing with external physical environment through numerous receptors interconnected with the nervous system. Scientists have been trying to transfer these features to artificial skin for a long time, aiming at robotic applications.

Read more ...

FDA Informs Health Care Providers, Facilities and Patients about Potential Cybersecurity Vulnerabilities

Today, the U.S. Food and Drug Administration is issuing a safety communication informing health care providers, facilities and patients about cybersecurity vulnerabilities identified for certain GE Healthcare Clinical Information Central Stations and Telemetry Servers. These devices are primarily used in health care facilities for

Read more ...

eHealthWeek 2020 Croatia - Trusted Information: Transforming Health & Care for All

15 - 17 April 2020, Rovinj, Croatia.
In its capacity of hosting the upcoming Presidency of the Council of the European Union, the Croatian Ministry of Health is in preparations to celebrate the 10th anniversary of the renowned eHealth conference, Europe's largest high-level digital health event.

Read more ...

VTT Makes New Investments in Digital Health

VTT is launching new research activities in the area of digital health as part of the growing wellbeing and health technology ecosystem in Kuopio. The new initiative aims to create state-of-the-art research based especially on the utilisation of health data, generate new digital health innovations and establish global health technology business in Finland and the Kuopio region.

Read more ...

AI in Drug Discovery Conference 2020

16 - 17 March 2020, London, UK.
SMi group presents the launch of the inaugural AI in Drug Discovery conference taking place in London. AI-empowered machine learning technologies hold the potential of reducing drug discovery associated costs by US$ 70 billion in the upcoming 10 years. With an estimated +39% CAGR, AI in drug discovery is

Read more ...

Refining Breast Cancer Classification by Multiplexed Imaging

Breast cancer progression can vary significantly between patients. Even within the same tumor, different areas may be composed of different types of cells and characterized by different tumor structures. This heterogeneity makes it challenging to ascertain the severity of a tumor and assess its molecular subtype, thereby affecting the precision of diagnosis and the choice of the most effective treatment approach.

Read more ...

Open Call SC1-HCO-19-2020: Reliable and Accessible Information on Cell and Gene-Based Therapies

Cell and gene-based therapies have the potential to treat many debilitating diseases and conditions. However, the pace of their clinical development does not meet public expectations. They face difficulties reaching patients because inter alia the complexity and costs of product development, regulatory hurdles and the non-harmonized procedures for reimbursements. In addition, there are concerns over patient safety due to the use of unproven treatments.

Read more ...